Cargando…
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression
Based on an increased frequency of early death (death within the first treatment cycle) in our two latest randomized trials of combination chemotherapy in small-cell lung cancer (SCLC), we wanted to identify patients at risk of early non-toxic death (ENTD) and early toxic death (ETD). Data were stor...
Autores principales: | Lassen, U N, Østerlind, K, Hirsch, F R, Bergman, B, Dombernowsky, P, Hansen, H H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362437/ https://www.ncbi.nlm.nih.gov/pubmed/10027322 http://dx.doi.org/10.1038/sj.bjc.6690080 |
Ejemplares similares
-
Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up.
por: Osterlind, K., et al.
Publicado: (1986) -
Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
por: Sørensen, J B, et al.
Publicado: (1999) -
Chromogranin A, a significant prognostic factor in small cell lung cancer
por: Drivsholm, L, et al.
Publicado: (1999) -
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001) -
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy
por: Sigsgaard, T, et al.
Publicado: (1999)